Oct. 14, 2026 — GLP-1 weight loss drugs known may help protect against heart failure even at doses too low to produce significant weight loss, according to a laboratory study led by Cedars-Sinai ...
Cardiovascular Clinical Studies
This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.
Nov. 2, 2026 — At the Transcatheter Cardiovascular Therapeutics (TCT) annual conference in San Diego, Calif. Medtronic ...
Nov. 1, 2026 – Abbott has announced the 30-day results from the TECTONIC Coronary Artery Disease (CAD) Intravascular ...
Nov. 1, 2026 — Heartflow, Inc. has announced new landmark randomized clinical data presented at Transcatheter ...
Oct. 27, 2026 — Atrium Therapeutics, developer of RNA therapeutics targeted to the heart, has announced that the first ...
Oct. 22, 2026 — For patients hospitalized with ischemic stroke and atrial fibrillation (AFib), restoring the heart’s ...
Oct. 22, 2026 — Henry Ford Health has performed the first procedures globally in a clinical trial evaluating pulmonary ...
Oct.19, 2026 – Jupiter Endovascular has announced publication of full results from its SPIRARE II pivotal trial evaluati ...
Oct. 14, 2026 — GLP-1 weight loss drugs known may help protect against heart failure even at doses too low to produce ...
Oct. 6, 2026 — Penumbra, Inc. has announced results from a subset analysis of the landmark STORM-PE randomized ...
Oct. 1, 2026 — W. L. Gore & Associates’ medical business (Gore) has announced the first patient enrollment in the IBE ...
Sept. 22, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai have received a $3.6 million, four-year ...
Sept. 22, 2026 — Despite decades of progress in cardiovascular science, women continue to face significant gaps in ...
Aug. 29, 2026— Vesalio recently announced results from the NATURE trial (NCT04969471), a prospective, randomized ...
Sept. 8, 2026 — New research1 indicates that people with invasive cancer face an elevated risk of experiencing a stroke ...
Aug. 31, 2026 — Amgen has announced new findings showing Repatha (evolocumab) reduced the risk of death in high-risk ...
November 04, 2026